ACAP1 and renal cell adenocarcinoma: Analysis from other ICT datasets, including an RCC dataset and an mUC dataset, showed that low ACAP1 expression was associated with inferior response, OS, and PFS in these patients, although this was not highly significant (Figure 9E,H).